These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 27799810)
1. Novel treatment options for lysosomal acid lipase deficiency: critical appraisal of sebelipase alfa. Su K; Donaldson E; Sharma R Appl Clin Genet; 2016; 9():157-167. PubMed ID: 27799810 [TBL] [Abstract][Full Text] [Related]
2. Long-term survival with sebelipase alfa enzyme replacement therapy in infants with rapidly progressive lysosomal acid lipase deficiency: final results from 2 open-label studies. Vijay S; Brassier A; Ghosh A; Fecarotta S; Abel F; Marulkar S; Jones SA Orphanet J Rare Dis; 2021 Jan; 16(1):13. PubMed ID: 33407676 [TBL] [Abstract][Full Text] [Related]
3. Enzyme replacement therapy in lysosomal acid lipase deficiency (LAL-D): a systematic literature review. Bashir A; Tiwari P; Duseja A Ther Adv Rare Dis; 2021; 2():26330040211026928. PubMed ID: 37181111 [TBL] [Abstract][Full Text] [Related]
4. Sebelipase Alfa: A Review in Lysosomal Acid Lipase Deficiency. Frampton JE Am J Cardiovasc Drugs; 2016 Dec; 16(6):461-468. PubMed ID: 27878737 [TBL] [Abstract][Full Text] [Related]
5. Sebelipase alfa in children and adults with lysosomal acid lipase deficiency: Final results of the ARISE study. Burton BK; Feillet F; Furuya KN; Marulkar S; Balwani M J Hepatol; 2022 Mar; 76(3):577-587. PubMed ID: 34774639 [TBL] [Abstract][Full Text] [Related]
7. Sebelipase alfa improves atherogenic biomarkers in adults and children with lysosomal acid lipase deficiency. Wilson DP; Friedman M; Marulkar S; Hamby T; Bruckert E J Clin Lipidol; 2018; 12(3):604-614. PubMed ID: 29628368 [TBL] [Abstract][Full Text] [Related]
8. Hepatic cholesteryl ester accumulation in lysosomal acid lipase deficiency: non-invasive identification and treatment monitoring by magnetic resonance. Thelwall PE; Smith FE; Leavitt MC; Canty D; Hu W; Hollingsworth KG; Thoma C; Trenell MI; Taylor R; Rutkowski JV; Blamire AM; Quinn AG J Hepatol; 2013 Sep; 59(3):543-9. PubMed ID: 23624251 [TBL] [Abstract][Full Text] [Related]
9. The role of sebelipase alfa in the treatment of lysosomal acid lipase deficiency. Erwin AL Therap Adv Gastroenterol; 2017 Jul; 10(7):553-562. PubMed ID: 28804516 [TBL] [Abstract][Full Text] [Related]
10. [Lysosomal acid lipase deficiency (LAL-D) : Diagnostic and therapeutic options in an underdiagnosed disease]. Synoracki S; Kathemann S; Schmid KW; Jastrow H; Baba HA Pathologe; 2018 May; 39(3):249-254. PubMed ID: 29234937 [TBL] [Abstract][Full Text] [Related]
12. Survival in infants treated with sebelipase Alfa for lysosomal acid lipase deficiency: an open-label, multicenter, dose-escalation study. Jones SA; Rojas-Caro S; Quinn AG; Friedman M; Marulkar S; Ezgu F; Zaki O; Gargus JJ; Hughes J; Plantaz D; Vara R; Eckert S; Arnoux JB; Brassier A; Le Quan Sang KH; Valayannopoulos V Orphanet J Rare Dis; 2017 Feb; 12(1):25. PubMed ID: 28179030 [TBL] [Abstract][Full Text] [Related]
13. Clinical outcome of a patient with lysosomal acid lipase deficiency and first results after initiation of treatment with Sebelipase alfa: A case report. Soll D; Spira D; Hollstein T; Haberbosch L; Demuth I; Steinhagen-Thiessen E; Bobbert T; Spranger J; Kassner U Mol Genet Metab Rep; 2019 Sep; 20():100479. PubMed ID: 31249784 [TBL] [Abstract][Full Text] [Related]
14. Sebelipase alfa for lysosomal acid lipase deficiency: 5-year treatment experience from a phase 2 open-label extension study. Malinová V; Balwani M; Sharma R; Arnoux JB; Kane J; Whitley CB; Marulkar S; Abel F Liver Int; 2020 Sep; 40(9):2203-2214. PubMed ID: 32657505 [TBL] [Abstract][Full Text] [Related]